Status:
UNKNOWN
Modifying Virtual Reality Analgesia With Low-Dose Pain Medication
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Virtual Reality Therapy
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The purpose of this study is to determine how pain relief is modified when the investigators combine the Virtual Reality based Snow World game with certain pain medications.
Detailed Description
This is a randomized, double-blind, placebo-controlled, within subject 2x2 factorial, repeated measures study. Research participants will play two versions of the Virtual Reality based video game "Sno...
Eligibility Criteria
Inclusion
- Healthy male and females between the age of 18 and 60 years
- Ability to communicate orally
- Ability to read and understand English
- Body Mass Index between 20-35
Exclusion
- Women who are pregnant, trying to become pregnant, or who are breastfeeding
- History of alcohol or substance abuse
- Major medical illness; including history of migraine headaches, seizures, brain injury, or peripheral neuropathy
- Current use of analgesics including acetaminophen, non-steroidal anti-inflammatories, or opioids
- Predisposition to severe motion sickness
- Unusual sensitivity or lack of sensitivity to pain
- Urine toxicology positive for opioids or benzodiazepines
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01840774
Start Date
April 1 2013
End Date
June 1 2014
Last Update
April 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98195